Is alendronate appropriate for treating Charcot neuroarthropathy of the left foot?

Do Not Use Alendronate for Charcot Neuroarthropathy

Do not use alendronate to treat Charcot neuroarthropathy of the left foot. The most recent and authoritative guidelines explicitly recommend against this intervention.

Clear Guideline Recommendation

The 2024 International Working Group on the Diabetic Foot (IWGDF) guidelines provide a strong recommendation with moderate-quality evidence stating: "Do not use alendronate, pamidronate, zoledronate, calcitonin, PTH, or methylprednisolone as treatment for active Charcot neuro-osteoarthropathy in a person with diabetes mellitus and intact skin" 1.

This is one of the few strong recommendations in these guidelines, indicating high confidence that the harms outweigh any potential benefits.

What You Should Do Instead

The cornerstone of treatment is mechanical offloading, not pharmacotherapy:

• Use a non-removable knee-high device (total contact cast as first choice, or non-removable knee-high walker as second choice) to immobilize and offload the foot 1
• Start this immediately once Charcot is suspected—do not delay for confirmatory testing 1
• Add assistive devices (crutches, walker) to further reduce weight-bearing on the affected limb 1

Why Bisphosphonates Don't Work

While the theoretical rationale seemed promising—Charcot involves excessive osteoclastic bone resorption via the RANKL-RANK-OPG pathway 2—the clinical evidence tells a different story:

• A 2026 systematic review and meta-analysis found that anti-resorptive agents (including alendronate) do not improve bone mineral density or provide clinically meaningful symptom relief beyond standard offloading 3
• Although these agents reduce bone resorption markers biochemically, this does not translate to improved clinical outcomes such as faster time to remission or reduced foot temperature 3, 4
• Multiple reviews from 2013 concluded the data was "not robust enough to convincingly demonstrate clinically meaningful effects" 5, 6

What About Vitamin D and Calcium?

The guidelines do suggest evaluating for vitamin D and calcium supplementation during the fracture healing phase, but this is fundamentally different from using anti-resorptive therapy 1. This addresses nutritional deficiencies that could impair healing, not the underlying inflammatory bone destruction of Charcot.

Common Pitfall to Avoid

Do not be tempted to add alendronate "just in case" or because the patient has concurrent osteoporosis. The FDA label for alendronate lists its indications as osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease 7—not Charcot neuroarthropathy. Using it off-label for Charcot is not supported by evidence and contradicts expert guidelines.

The Bottom Line Algorithm

1. Diagnose Charcot (warm, swollen foot with neuropathy; confirm with MRI if X-rays normal) 1
2. Immediately apply non-removable knee-high offloading device 1
3. Do NOT prescribe alendronate or other bisphosphonates 1
4. Consider vitamin D/calcium supplementation only if deficient 1
5. Monitor for remission using temperature differential, edema, and imaging 1
6. Transition to custom footwear/orthoses once in remission to prevent reactivation 1